186 related articles for article (PubMed ID: 30360735)
1. Snake Venom Disintegrins: An Overview of their Interaction with Integrins.
Cesar PHS; Braga MA; Trento MVC; Menaldo DL; Marcussi S
Curr Drug Targets; 2019; 20(4):465-477. PubMed ID: 30360735
[TBL] [Abstract][Full Text] [Related]
2. Disintegrins from snake venoms and their applications in cancer research and therapy.
Arruda Macêdo JK; Fox JW; de Souza Castro M
Curr Protein Pept Sci; 2015; 16(6):532-48. PubMed ID: 26031306
[TBL] [Abstract][Full Text] [Related]
3. Applications of snake venom components to modulate integrin activities in cell-matrix interactions.
Marcinkiewicz C
Int J Biochem Cell Biol; 2013 Sep; 45(9):1974-86. PubMed ID: 23811033
[TBL] [Abstract][Full Text] [Related]
4. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review.
Schönthal AH; Swenson SD; Chen TC; Markland FS
Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic insights of snake venom disintegrins in cancer treatment.
Akhtar B; Muhammad F; Sharif A; Anwar MI
Eur J Pharmacol; 2021 May; 899():174022. PubMed ID: 33727054
[TBL] [Abstract][Full Text] [Related]
6. Snake venom metalloproteinases and disintegrins: interactions with cells.
Kamiguti AS; Zuzel M; Theakston RD
Braz J Med Biol Res; 1998 Jul; 31(7):853-62. PubMed ID: 9698750
[TBL] [Abstract][Full Text] [Related]
7. [Snake venom disintegrins: classification and therapeutic potential].
Kallech-Ziri O; Luis J; El Ayeb M; Marrakchi N
Arch Inst Pasteur Tunis; 2007; 84(1-4):29-37. PubMed ID: 19388581
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of pancreatic tumoral cells by snake venom disintegrins.
Lucena S; Castro R; Lundin C; Hofstetter A; Alaniz A; Suntravat M; Sánchez EE
Toxicon; 2015 Jan; 93():136-43. PubMed ID: 25450798
[TBL] [Abstract][Full Text] [Related]
9. Antitumoral Potential of Lansbermin-I, a Novel Disintegrin from Porthidium lansbergii lansbergii Venom on Breast Cancer Cells.
Montealegre-Sánchez L; Gimenes SNC; Lopes DS; Teixeira SC; Solano-Redondo L; de Melo Rodrigues V; Jiménez-Charris E
Curr Top Med Chem; 2019; 19(22):2069-2078. PubMed ID: 31385773
[TBL] [Abstract][Full Text] [Related]
10. Disintegrins extracted from totonacan rattlesnake (Crotalus totonacus) venom and their anti-adhesive and anti-migration effects on MDA-MB-231 and HMEC-1 cells.
Rivas Mercado E; Neri Castro E; Bénard Valle M; Rucavado-Romero A; Olvera Rodríguez A; Zamudio Zuñiga F; Alagón Cano A; Garza Ocañas L
Toxicol In Vitro; 2020 Jun; 65():104809. PubMed ID: 32087267
[TBL] [Abstract][Full Text] [Related]
11. Snake venom disintegrins and cell migration.
Selistre-de-Araujo HS; Pontes CL; Montenegro CF; Martin AC
Toxins (Basel); 2010 Nov; 2(11):2606-21. PubMed ID: 22069567
[TBL] [Abstract][Full Text] [Related]
12. Colombistatin: a disintegrin isolated from the venom of the South American snake (Bothrops colombiensis) that effectively inhibits platelet aggregation and SK-Mel-28 cell adhesion.
Sánchez EE; Rodríguez-Acosta A; Palomar R; Lucena SE; Bashir S; Soto JG; Pérez JC
Arch Toxicol; 2009 Mar; 83(3):271-9. PubMed ID: 18830584
[TBL] [Abstract][Full Text] [Related]
13. Functional characteristic of snake venom disintegrins: potential therapeutic implication.
Marcinkiewicz C
Curr Pharm Des; 2005; 11(7):815-27. PubMed ID: 15777236
[TBL] [Abstract][Full Text] [Related]
14. How snake venom disintegrins affect platelet aggregation and cancer proliferation.
Kolvekar N; Bhattacharya N; Sarkar A; Chakrabarty D
Toxicon; 2023 Jan; 221():106982. PubMed ID: 36435228
[TBL] [Abstract][Full Text] [Related]
15. Snake venom probes of platelet adhesion receptors and their ligands.
Wijeyewickrema LC; Berndt MC; Andrews RK
Toxicon; 2005 Jun; 45(8):1051-61. PubMed ID: 15922774
[TBL] [Abstract][Full Text] [Related]
16. Non-RGD-containing snake venom disintegrins, functional and structural relations.
Walsh EM; Marcinkiewicz C
Toxicon; 2011 Sep; 58(4):355-62. PubMed ID: 21801741
[TBL] [Abstract][Full Text] [Related]
17. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
[TBL] [Abstract][Full Text] [Related]
18. Structural requirements of MLD-containing disintegrins for functional interaction with alpha 4 beta 1 and alpha 9 beta1 integrins.
Bazan-Socha S; Kisiel DG; Young B; Theakston RD; Calvete JJ; Sheppard D; Marcinkiewicz C
Biochemistry; 2004 Feb; 43(6):1639-47. PubMed ID: 14769041
[TBL] [Abstract][Full Text] [Related]
19. Snake venom disintegrins: evolution of structure and function.
Calvete JJ; Marcinkiewicz C; Monleón D; Esteve V; Celda B; Juárez P; Sanz L
Toxicon; 2005 Jun; 45(8):1063-74. PubMed ID: 15922775
[TBL] [Abstract][Full Text] [Related]
20. Thrombolytic effects of the snake venom disintegrin saxatilin determined by novel assessment methods: a FeCl3-induced thrombosis model in mice.
Kwon I; Hong SY; Kim YD; Nam HS; Kang S; Yang SH; Heo JH
PLoS One; 2013; 8(11):e81165. PubMed ID: 24260554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
